News

  • January 19th, 2024 - Press notes

    Dr. Helena Tizón is the new director of the Comprehensive Plan for Cardiovascular Diseases in Catalonia, focusing on cardiovascular diseases

    Dr. Helena Tizón is the new director of the Comprehensive Plan for Cardiovascular Diseases in Catalonia, focusing on cardiovascular diseases The Minister of Health officially announced the cardiologist's appointment from Hospital del Mar and researcher at the Hospital del Mar Research Institute last December. Dr. Tizón replaces Dr. Josepa Mauri from Hospital Germans Trias i Pujol, who held this position for the past 8 years.

    more information

  • January 10, 2024 - Press notes

    Discovering a Defective Class of Neurons in the Brains of Individuals with Schizophrenia

    Discovering a Defective Class of Neurons in the Brains of Individuals with Schizophrenia Functional alterations in the brains of individuals with this condition coincide with the distribution of these neurons in the same brain. These neurons are responsible for filtering external information reaching the brain. Their functioning is altered in individuals with schizophrenia, which explains the majority of their symptoms. This discovery is the first time that this alteration can be identified as a possible origin of schizophrenic symptoms, and it opens the door to seeking new targeted treatments with fewer patient side effects.

    more information

  • 28 december 2023 - Press notes

    The smallpox vaccine effectively induces immunity against monkeypox virus infection in people with HIV

    An observational study conducted by researchers from Pompeu Fabra University and Hospital del Mar determines that the intradermal administration of the JYNNEOS vaccine against smallpox induces an efficient immune response that should protect people living with HIV from contracting the monkeypox virus.

    more information

  • 19th December, 2023 - Press notes

    The results of research into a new oral treatment for COVID-19 has been published

    The results of research into a new oral treatment for COVID-19 has been published A clinical trial carried out by Hospital del Mar, Pompeu Fabra University, the Health Research Institute of Santiago de Compostela and the Pere Virgili Health Park investigated the efficacy and safety of a medicine for outpatients with COVID-19. The treatment acts on the replication mechanism of SARS-CoV-2, the virus responsible for the disease, and reduces the severity and duration of some of the symptoms. In addition, it can be useful to treat the different mutations detected. Were its usefulness for treating COVID-19 confirmed, it would be one of the first drugs that could be given to primary care patients to prevent their condition from worsening and requiring hospital admission.

    more information

  • 11 de diciembre de 2023 - Press notes

    The presence of professionals from the Hospital del Mar increases in Stanford University's World's Top 2% Scientist ranking

    The presence of professionals from the Hospital del Mar increases in Stanford University's World's Top 2% Scientist ranking The Hospital del Mar and the Hospital del Mar Research Institute have achieved a record number of professionals, with 33 present in the new edition of the World's Top 2% Scientist, a ranking compiled by Stanford University in the United States.

    more information

  • November 29th, 2023 - Press notes

    Study Shows that Premature Aging in People with HIV is Caused by the Infection Itself, Not Just Antiretroviral Treatment

    Study Shows that Premature Aging in People with HIV is Caused by the Infection Itself, Not Just Antiretroviral Treatment People with HIV have altered levels of a specific RNA molecule related to both aging and inflammation. This molecule remains altered even with antiretroviral treatment, indicating that their immune system remains affected despite receiving antiretroviral treatment and controlling the infection. The authors of the study, published in the Journal of Microbiology, Immunology, and Infection, suggest that the origin of this alteration is chronic inflammation caused by the infection, regardless of the treatment received by patients. Having this marker can be helpful in monitoring the evolution of patients and the effectiveness of the drugs they take to restore the normal functioning of their immune system.

    more information

  • November 24th, 2023 - Press notes

    "La Caixa" Foundation promotes research in biomedicine and health in Spain and Portugal by calling for proposals endowed with 25.3 million euros

    33 new research projects received funding of up to 500,000 euros or up to one million euros in the sixth edition of the CaixaResearch Health Research call, promoted by the "la Caixa" Foundation. In total, 25.3 million euros in grants. The call supports basic, clinical, or translational research projects with scientific excellence and social impact in cardiovascular diseases, infections, oncology, and neurosciences. It also supports projects developing enabling technologies in these areas. Among the selected projects is one led by Dr. Toni Celià-Terrassa to advance the understanding of metastasis and its coevolution with the immune system. There are also two other projects with the participation of researchers from the Hospital del Mar, Dr. Víctor Pérez, and Dr. Arnau Busquets.

    more information

  • November 17th, 2023 - Press notes

    Proposed New Approach for the Treatment of Antibiotic-Resistant Bacteria-Induced Pneumonia

    Proposed New Approach for the Treatment of Antibiotic-Resistant Bacteria-Induced Pneumonia Researchers from the Hospital del Mar Research Institute have published a new article in Microbiology Spectrum proposing a novel approach to treating pneumonia caused by antibiotic-resistant Pseudomonas aeruginosa bacteria. The study suggests that increasing the dose of the antibiotic colistin may not only be ineffective but could also increase patient mortality For this reason, the researchers advocate for using nebulized administration of the treatment instead of intravenous administration. This approach achieves higher concentrations in the lungs, where the infection is located, without causing toxic colistin concentrations in the blood The World Health Organization considers antibiotic resistance among the top 10 global public health threats

    more information

  • November 13th, 2023 - COVID-19

    Neurologists at Hospital de Mar to Run 24 Hours for ALS

    Neurologists at Hospital de Mar to Run 24 Hours for ALS We encourage everyone worldwide to join the ALS cause by supporting it with their contributions to professionals in their fight against a disease that challenges hope.

    more information

  • October 26th, 2022 - Press notes

    A possible new combination of treatments to combat cancer

    A possible new combination of treatments to combat cancer A study involving the Hospital del Mar Research Institute, the Vall d'Hebron Institut d'Oncologia, IDIBELL, and the Institut Català d'Oncologia suggests that combining chemotherapy with drugs that can inhibit two cell signaling pathways involved in tumor progression may aid in treatment. The research has analyzed the interaction of the protein IKKα with these pathways, known for their ability to promote the proliferation of tumor cells. This combination has the advantage of reducing treatment toxicity. The study opens the door to new approaches for tumors with the presence of this protein. It is published in the EMBO Journal.

    more information

Social commitment

  • Social commitment
Collaborating entity

© 2006 - 2024 Parc de Salut Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility